tag:www.gov.uk,2005:/government/organisations/medicines-and-healthcare-products-regulatory-agency Medicines and Healthcare products Regulatory Agency - Activity on 바카라 사이트 HM 바카라 사이트 2025-06-06T14:16:25Z /guidance/access-new-active-substance-nas-work-sharing-initiative#2025-06-06T14:16:25Z 2025-06-06T14:16:25Z Access, new active substance and biosimilar work sharing initiatives Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products. /government/news/mhra-launches-new-digital-hub-in-leeds-to-drive-innovation-and-regional-growth#2025-06-06T13:31:37Z 2025-06-06T13:31:37Z MHRA launches new digital hub in Leeds to drive innovation and regional growth The new hub will strengthen the MHRA바카라 사이트s work with regional partners and boost the UK바카라 사이트s digital health and life sciences sector. /government/publications/orphan-registered-medicinal-products#2025-06-06T12:29:50Z 2025-06-06T12:29:50Z Decision: Orphan registered medicinal products A list of authorised orphan medicinal products registered by the UK licensing authority. /drug-device-alerts/field-safety-notices-19-to-23-may-2025#2025-06-06T12:18:06Z 2025-06-06T12:18:06Z Field Safety Notices: 19 to 23 May 2025 List of Field Safety Notices from 19 to 23 May 2025. /government/publications/human-and-veterinary-medicines-register-of-licensed-wholesale-distribution-sites#2025-06-05T14:20:17Z 2025-06-05T14:20:17Z Decision: Human and veterinary medicines: register of licensed wholesale distribution sites Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human and veterinary). /government/publications/medicines-new-manufacturing-and-wholesale-dealer-licences#2025-06-05T14:16:21Z 2025-06-05T14:16:21Z Decision: Medicines: new manufacturing and wholesale dealer licences List of sites granted a manufacturer or wholesale dealer licence. /government/publications/human-and-veterinary-medicines-register-of-licensed-manufacturing-sites#2025-06-05T14:10:18Z 2025-06-05T14:10:18Z Decision: Human and veterinary medicines: register of licensed manufacturing sites The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only. /government/publications/medicines-terminated-and-cancelled-manufacturing-and-wholesale-dealer-licences#2025-06-05T14:05:17Z 2025-06-05T14:05:17Z Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled. /government/publications/register-of-brokers-authorised-to-deal-in-human-medicines#2025-06-05T14:02:35Z 2025-06-05T14:02:35Z Notice: Register of brokers authorised to deal in human medicines Current listing of UK brokers authorised to broker human medicines, including company name, registration and address. /government/publications/human-medicines-register-of-electronic-export-certificates#2025-06-05T13:42:10Z 2025-06-05T13:42:10Z Decision: Human medicines: register of electronic export certificates Department of Health and Social Care and MHRA register of electronic export certificates (human). /government/news/helping-bring-phage-medicines-to-uk-patients-guidance-for-industry#2025-06-05T08:44:17Z 2025-06-05T08:44:17Z Helping bring phage medicines to UK patients 바카라 사이트 guidance for industry Bacteriophages 바카라 사이트 viruses that selectively fight bacteria 바카라 사이트 may offer new hope in fighting infections and tackling antimicrobial resistance. /government/news/women-on-skinny-jabs-must-use-effective-contraception-mhra-urges-in-latest-guidance#2025-06-04T23:01:03Z 2025-06-04T23:01:03Z Women on 바카라 사이트skinny jabs바카라 사이트 must use effective contraception, MHRA urges in latest guidance  Anyone who suspects that they바카라 사이트ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA.  /government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know#2025-06-04T23:01:03Z 2025-06-04T23:01:03Z Guidance: GLP-1 medicines for weight loss and diabetes: what you need to know Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes. /government/publications/regulatory-considerations-for-therapeutic-use-of-bacteriophages-in-the-uk#2025-06-04T10:02:19Z 2025-06-04T10:02:19Z Guidance: Regulatory considerations for therapeutic use of bacteriophages in the UK This publication clarifies which regulatory guidelines should be followed, and which apply, in the development of phage therapeutic products. /guidance/regulatoryconnect#2025-06-04T09:47:30Z 2025-06-04T09:47:30Z RegulatoryConnect The Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details. /government/publications/disapplication-of-falsified-medicines-directive-safety-features-requirements-for-parallel-imports#2025-06-03T13:54:12Z 2025-06-03T13:54:12Z Guidance: Disapplication of Falsified Medicines Directive Safety Features: Requirements for Parallel Imports Information relating to the disapplication of falsified medicines under UK Law. /government/publications/uk-parallel-import-licences-following-agreement-of-the-windsor-framework#2025-06-03T13:52:44Z 2025-06-03T13:52:44Z Guidance: UK parallel import licences following agreement of the Windsor Framework Information relating to parallel imports and the implementation of the Windsor Framework. /drug-device-alerts/field-safety-notices-26-to-30-may-2025#2025-06-03T09:26:52Z 2025-06-03T09:26:52Z Field Safety Notices: 26 to 30 May 2025 List of Field Safety Notices from 26 to 30 May 2025. /government/news/mhra-approves-aumolertinib-to-treat-non-small-cell-lung-cancer#2025-06-02T23:00:00Z 2025-06-02T23:00:00Z MHRA approves aumolertinib to treat non-small cell lung cancer As with all products, we will keep its safety under close review /drug-device-alerts/class-4-medicines-notification-zentiva-pharma-uk-limited-various-products-el-25-a-slash-24#2025-06-02T10:01:44Z 2025-06-02T10:01:44Z Class 4 Medicines Notification, Zentiva Pharma UK Limited, Various Products, EL(25)A/24 Zentiva Pharma UK Limited has informed the MHRA of an issue related to batches of various soluble or effervescent tablets.